Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.32 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14188552 | 0.92 | ALDH1A1 (0.36) | ALDH1A1CYP2D6POLBESR2CYP2C19 | |
| SCHEMBL20348449 | 0.91 | ALDH1A1 (0.35) | ALDH1A1CYP2D6POLBESR2CYP2C19 | |
| SCHEMBL4257289 | 0.88 | ALDH1A1 (0.39) | ALDH1A1CYP2D6POLBESR2CYP2C19 | |
| SCHEMBL5895577 | 0.85 | TSHR (0.37) | ALDH1A1CYP2D6L3MBTL1MAPK1PRMT5 | |
| SCHEMBL4257136 | 0.85 | SMN1; SMN2 (0.50) | ALDH1A1CYP2D6POLBESR2CYP2C19 | |
| SCHEMBL13321811 | 0.85 | ALDH1A1 (0.37) | ALDH1A1CYP2D6POLBESR2CYP2C19 | |
| SCHEMBL12361954 | 0.84 | ALDH1A1 (0.36) | ALDH1A1CYP2D6CYP2C19MEN1KMT2A | |
| SCHEMBL25153489 | 0.84 | ALDH1A1 (0.37) | ALDH1A1CYP2D6POLBESR2CYP2C19 | |
| SCHEMBL4263623 | 0.84 | ALDH1A1 (0.50) | ALDH1A1CYP2D6 | |
| SCHEMBL4269337 | 0.83 | L3MBTL1 (0.33) | ALDH1A1CYP2D6POLBESR2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210221933-A1 | CONDUCTIVE POLYMER MATERIAL AND USE THEREOF | ETERNAL MATERIALS CO., LTD. (TW) | 2021-07-22 | — | — | US | disclosed |
| US-7999121-B2 | Derivatized 3,4-alkylenedioxythiophene monomers, methods of making them, and use thereof | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-08-16 | — | — | US | disclosed |
| US-20110024693-A1 | DERIVATIZED 3,4-ALKYLENEDIOXYTHIOPHENE MONOMERS, METHODS OFMAKING THEM, AND USE THEREOF | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-02-03 | — | — | US | disclosed |
| US-7838688-B2 | dehalogenation and hydrolysis to form a water soluble polythiophene monomer; PEDOT electroconductive polymers | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-11-23 | — | — | US | disclosed |
| EP-1327645-B1 | Process for the production of neutral poly(ethylenedioxythiophene) and related poly(ethylenedioxythiophenes) | STARCK H C GMBH (DE) | 2009-10-21 | — | — | EP | disclosed |
| US-20090008609-A1 | dehalogenation and hydrolysis to form a water soluble polythiophene monomer; PEDOT electroconductive polymers | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-01-08 | — | — | US | disclosed |
| US-6756473-B2 | REACTING WITH OXIDIZER; APPLYING TO SUBSTRATE | BAYER AKTIENGESELLSCHAFT (DE) | 2004-06-29 | — | — | US | disclosed |
| US-20030139505-A1 | Process for the preparation of neutral polyethylenedioxythiophene, and corresponding polyethylenedioxythiophenes | HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) | 2003-07-24 | — | — | US | disclosed |
| EP-1327645-A1 | Process for the production of neutral poly(ethylenedioxythiophene) and related poly(ethylenedioxythiophenes) | Bayer Aktiengesellschaft (DE) | 2003-07-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110024693-A1 | DERIVATIZED 3,4-ALKYLENEDIOXYTHIOPHENE MONOMERS, METHODS OFMAKING THEM, AND USE THEREOF | AS3MT, TET3, TET2 | ALDH1A1 220/4885CYP2D6 673/4885POLB 3587/4885 |
| US-20090008609-A1 | dehalogenation and hydrolysis to form a water soluble polythiophene monomer; PEDOT electroconductive polymers | HPD, HAAO, DDT | ALDH1A1 433/4885CYP2D6 137/4885POLB 1072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.